Navigation Links
Veracyte, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2014 Financial Results on August 13, 2014
Date:8/6/2014

SOUTH SAN FRANCISCO, Calif., Aug. 6, 2014 /PRNewswire/ -- Veracyte, Inc. (Nasdaq: VCYT) announced today that its second quarter 2014 financial results will be released after close of market on Wednesday, August 13, 2014.  Following the announcement, Veracyte's management will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the company's financial results and provide a general business update.   

The live webcast and subsequent replay may be accessed by visiting Veracyte's website at http://investor.veracyte.com. Please connect to the website at least 15 minutes prior to the live webcast to ensure adequate time for any necessary software download. Alternatively, please call (855) 541-0980 (U.S.) or (970) 315-0440 (international) to listen to the live conference call. The conference ID number for the live call is 79445857. Please dial in approximately 10 minutes prior to the call. The webcast will be available on the company's website approximately two hours following completion of the call for 14 days.

About Veracyte

Veracyte (Nasdaq: VCYT) is pioneering the field of molecular cytology, focusing on genomic solutions that resolve diagnostic ambiguity and enable physicians to make more informed treatment decisions at an early stage in patient care. By improving preoperative diagnostic accuracy, the company aims to help patients avoid unnecessary invasive procedures while reducing healthcare costs. Veracyte's first commercial solution, the Afirma® Thyroid FNA Analysis, provides a comprehensive approach for assessing thyroid nodules, centered on the proprietary Gene Expression Classifier (GEC) to resolve ambigu
'/>"/>

SOURCE Veracyte
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Veracyte, Inc. Announces Pricing of Initial Public Offering
2. Veracyte, Inc. to Announce Third Quarter 2013 Financial Results and Host Conference Call on Monday, November 25, 2013
3. Veracyte, Inc. Announces Third Quarter 2013 Financial Results
4. Thoratec Schedules First Quarter Conference Call, Webcast
5. Watson to Host Conference Call and Webcast to Discuss First Quarter 2012 Earnings
6. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
7. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
8. Austen BioInnovation Institute in Akron Attracts Nationally Known Speakers For Conference on Value-driven Engineering, April 23-24
9. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
10. Insmed to Host 2012 First Quarter Earnings Conference Call
11. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Reductions in kidney ... years in people with diabetes type 2 ... benefits for the kidneys." Australian researchers have ... 2 diabetes leads to persistent reductions in kidney failure ... The global study has found that, five and a ...
(Date:9/18/2014)... , September 19, 2014 ... Markets ( http://www.researchandmarkets.com/research/qqjrnh/global_molecular ) has announced the ... Market 2014-2018" report to their offering. ... Cytogenetics involves the study of chromosomes using ... functions of genes and chromosomes. It plays ...
(Date:9/18/2014)... , Sept. 18, 2014  Aratana Therapeutics, ... therapeutics company focused on licensing, developing and commercializing ... the full exercise of the underwriters, option to ... connection with the company,s previously announced public offering ... the shares are being offered by Aratana Therapeutics.  ...
Breaking Medicine Technology:ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2
... Response or Reduction of,Lesion Size by More than ... 2007 /PRNewswire-FirstCall/ - Nventa,Biopharmaceuticals Corporation today announced the ... the safety and,efficacy of pilot process HspE7, an ... women,with the highest grade of cervical dysplasia (CIN ...
... WIRE)--Mar 7, 2007 - BioLineRx Ltd.,(TASE:BLRX), Israel's ... from trials of BL-1040 demonstrating that,BL-1040 is ... a myocardial infarction (MI), thereby reducing left ... pig model. Professor,Jonathan Leor, MD, Director of ...
Cached Medicine Technology:Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 2Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 3Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 4Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 5Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia 6BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 2BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality 3
(Date:9/19/2014)... September 19, 2014 Outsourcing services provider Profit ... large US IT conglomerate to provide HR outsourcing services in ... as an exclusive partner and will act as a talent ... will deploy over 120 personnel across 3 locations in India ... statement. , "This is a significant win for us and ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Dr. John ... Therapeutic Periodontal Treatment to their Miami practice. Routinely ... Gallardo and Dr. Lamas are one of the ... ‘total health’ approach for diagnosing and treating periodontal disease. ... the most under-diagnosed and under-treated diseases in the world. ...
(Date:9/19/2014)... Dennis Thompson HealthDay Reporter ... President Barack Obama escalated the fight against antibiotic-resistant bacteria ... national strategy to deal with the threat. ... cabinet-level task force charged with crafting a national action ... ordinary and previously treatable bacteria that have become resistant ...
(Date:9/19/2014)... Chino Hills, CA (PRWEB) September 19, 2014 ... the fastest-selling fitness boot camp in the country. He’s also ... mentoring thousands of clients, coaching celebrity trainers and serving as ... He knows marketing, and he says that becoming an integral ... camp’s success. , “One of the things that Fit Body ...
(Date:9/19/2014)... DC (PRWEB) September 19, 2014 Atlantic ... and the authoritative AIS’s Directory of Health Plans — ... Facts, Trends and Data: 2014-2015. The latest edition of ... are re-shaping the health care industry. , With ... plan issues — from benefit design and management strategies ...
Breaking Medicine News(10 mins):Health News:Profit By RPO Bags huge RPO contract from US-based Implementation Partner 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 3Health News:Obama Calls for National Plan to Fight Antibiotic Resistance 2Health News:New Post from Boot Camp Marketing Expert Bedros Keuilian Explains Importance of Becoming Part of the Community 2Health News:New Post from Boot Camp Marketing Expert Bedros Keuilian Explains Importance of Becoming Part of the Community 3Health News:New Book from Atlantic Information Provides Insights Into Trends in the Health Care Industry 2
... but along with her, her families too have to face the ... breast has taken its toll on Ellen who is finding it ... Her family could seem to do nothing to ease the pain. ... palliative care team at Dartmouth Hitchcock Medical Center. ,A doctor ...
... they get married is a waste of breath, a US ... Sydney. // ,William Smith, the vice president of the ... that a six-year study commissioned by the US Congress found ... spent on pushing sexual abstinence outside marriage had had no ...
... only getting closer for the Bush administration and therefore many ... the one cited by the American Civil Liberties Union; they ... the federally sponsored ‘Abstinence Only Sex Education’ programme. ,The ... document compiled by Dr. John Santelli, a pediatrician at the ...
... A mental fog referred to as ‘chemo brain’ that ... it deserves. // , Patients especially women have ... as short-term memory loss, an inability to concentrate, difficulty ... that they had lost their mental edge. Once brushing ...
... found a breakthrough method of blood test to diagnose Parkinson ... blood much before the symptoms arrive. The test is done ... Institute and Melbourne University specialists. ,They have also ... application as it can screen many types of PD and ...
... interfere with the therapeutic effects of chemotherapy agents, ... use of antioxidants during chemotherapy. In fact, they ... the patient’s ability to tolerate treatment. This conclusion ... the use of antioxidant supplements during treatment. Until ...
Cached Medicine News:Health News:The Pain Relieved With the Help of Palliative Workers 2Health News:Chemo Brain- Nothing Forgettable About It 2Health News:Chemo Brain- Nothing Forgettable About It 3Health News:New Blood Test to Diagnose Parkinson Disease 2Health News:Antioxidants May Aid Chemotherapy Patients 2
Nitinol Flat Wire Basket...
1.5 Fr Nitinol Tipless Stone Basket...
Agglutinating sera for serological identification of E. coli by slide and/or tube agglutination tests. Agglutinating sera are packaged 2 mL / vial....
A direct qualitative enzyme immunoassay for detection of E.coli Shiga Toxin 1 and 2 in fresh or preserved fecal specimens....
Medicine Products: